TERT promoter mutations have been identified in ∼9% of papillary thyroid cancers and 40–73% of advanced thyroid cancers, where they are associated with a more aggressive clinical course (Cancer Genome Atlas Research, 2014; Liu et al., 2013; Landa et al., 2016). This evidence concerns the gene TERT and thyroid gland papillary carcinoma.